Warrants for up to 52.1M shares face an ownership cap at Taysha Gene Therapies (TSHA).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
RA Capital Management, L.P. and affiliated entities reported an amended beneficial ownership of 32,785,574 shares, representing 9.99% of Taysha Gene Therapies (TSHA) as of September 30, 2026. This includes pre-funded warrants exercisable for up to 52,134,718 shares, but a beneficial ownership blocker prevents exercising warrants if it would exceed the 9.99% threshold.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.